Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020

Neuro-Oncology(2024)10.1093/neuonc/noae115Source: DataRank Database

Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020 is a research paper published in Neuro-Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.50)OA: greenTopics (54)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Michael Scordo ORCID,Joachim Yahalom ORCID,Charlie White ORCID,Zhigang Zhang ORCID,Behroze Vachha ORCID

Live enrichment

PubMed:38915246 OpenAlex:https://openalex.org/W4400018518

National Institutes of Health

Grant: P30 CA008748

Lacher Lymphoma Foundation

Connecticut Cancer Foundation

FWCI

3.50

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11534311/pdf/noae115.pdf

publisherhttps://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noae115/58598567/noae115.pdf

publisherhttps://academic.oup.com/neuro-oncology/article-pdf/26/11/2061/60416271/noae115.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11534311

Fields of Study

CNS Lymphoma Diagnosis and TreatmentGlioma Diagnosis and TreatmentLymphoma Diagnosis and TreatmentHumansMaleFemaleMiddle AgedCentral Nervous System NeoplasmsNeoplasm Recurrence, LocalAgedAdultFollow-Up StudiesLongitudinal StudiesSurvival RateYoung AdultLymphoma, Large B-Cell, DiffuseAged, 80 and overPrognosisAdolescentRetrospective StudiesAntineoplastic Combined Chemotherapy Protocols

MeSH Terms

AdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsFemaleFollow-Up StudiesHumansLongitudinal StudiesMaleMiddle AgedNeoplasm Recurrence, LocalPrognosisRetrospective StudiesSurvival RateLymphoma, Large B-Cell, DiffuseCentral Nervous System NeoplasmsYoung Adult

Keywords

Cumulative incidenceMedicinePrimary central nervous system lymphomaInternal medicineCohortRefractory (planetary science)Incidence (geometry)LymphomaGastroenterologyOncologySurgeryconsolidationimagingpatterns of failureradiation therapy

Sustainable Development Goals

SDG 0: Good health and well-being